Samuel David Tweardy

This profile gathers the share dealings of Samuel David Tweardy in Tvardi Therapeutics, Inc. In total, 2 filings cover trades dated 7 July 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 5 August 2025, reports a transaction in Tvardi Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.